Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Iran |
First Approval Date14 Jun 2021 |
100 Clinical Results associated with Shifa Pharmaceutical Industries Sabouni & Co.
0 Patents (Medical) associated with Shifa Pharmaceutical Industries Sabouni & Co.
100 Deals associated with Shifa Pharmaceutical Industries Sabouni & Co.
100 Translational Medicine associated with Shifa Pharmaceutical Industries Sabouni & Co.